Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite–induced allergic rhinitis

MLA

Toru Imai, et al. “Efficacy and Safety of the SQ House Dust Mite Sublingual Immunotherapy Tablet in Japanese Adults and Adolescents with House Dust Mite–induced Allergic Rhinitis.” Journal of Allergy and Clinical Immunology, vol. 139, June 2017, p. 1840–1848.e10. EBSCOhost, https://doi.org/10.1016/j.jaci.2016.09.043.

APA

Toru Imai, Brian Sonne Stage, Akiyoshi Konno, Kazuhiro Okamiya, Kimihiro Okubo, Dorthe Seitzberg, & Keisuke Masuyama. (2017). Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite–induced allergic rhinitis. Journal of Allergy and Clinical Immunology, 139, 1840–1848.e10. https://doi.org/10.1016/j.jaci.2016.09.043

Chicago

Toru Imai, Brian Sonne Stage, Akiyoshi Konno, Kazuhiro Okamiya, Kimihiro Okubo, Dorthe Seitzberg, and Keisuke Masuyama. 2017. “Efficacy and Safety of the SQ House Dust Mite Sublingual Immunotherapy Tablet in Japanese Adults and Adolescents with House Dust Mite–induced Allergic Rhinitis.” Journal of Allergy and Clinical Immunology 139 (June): 1840–1848.e10. doi:10.1016/j.jaci.2016.09.043.